Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The menopause in Europe.

S Rozenberg1, C Fellemans, M Kroll

  • 1Department of Obtetrics and Gynecology, Free University of Brussels (ULB), Hospital St. Pierre, Belgium.

International Journal of Fertility and Women'S Medicine
|June 1, 2000
PubMed
Summary

Hormone replacement therapy (HRT) effectively manages menopausal symptoms and prevents osteoporosis. However, HRT use varies significantly across European countries, necessitating further analysis of influencing factors and usage patterns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Menopausal hormone therapy and ovarian cancer: Risk assessment of various regimens and risk evaluation in ovarian cancer survivors.

Maturitas·2026
Same author

Menopausal hormone therapy and endometrial cancer: Risk assessment of various regimens and risk evaluation for endometrial cancer survivors.

Maturitas·2026
Same author

Randomized trial: treatment of genitourinary syndrome of menopause using radiofrequency.

Climacteric : the journal of the International Menopause Society·2024
Same author

Does the freeze-all strategy improve the cumulative live birth rate and the time to become pregnant in IVF cycles?

Archives of gynecology and obstetrics·2021
Same author

MOF/Hip Fracture Ratio in a Belgian Cohort of Post-menopausal Women (FRISBEE): Potential Impact on the FRAX® Score.

Calcified tissue international·2021
Same author

Discriminating value of HR-pQCT for fractures in women with similar FRAX scores: A substudy of the FRISBEE cohort.

Bone·2020

Area of Science:

  • Gynecology
  • Endocrinology
  • Public Health

Background:

  • Menopause affects a significant portion of women's lives, often accompanied by debilitating vasomotor and urogenital symptoms.
  • Accelerated bone loss post-menopause increases osteoporosis risk, a major health concern for aging women.
  • Hormone replacement therapy (HRT) is a primary treatment for menopausal symptoms and osteoporosis prevention.

Purpose of the Study:

  • To analyze the prevalence of menopausal symptoms and related health issues in European women.
  • To examine the trends in HRT use, including types and administration methods, across Europe over the past decade.
  • To investigate factors contributing to the heterogeneity in HRT utilization among European countries.

Main Methods:

  • Review of epidemiological data on menopausal symptoms and health issues in Europe.
  • Analysis of HRT prescription data and usage patterns across different European nations.
  • Exploration of socioeconomic and cultural factors potentially influencing HRT adoption.

Main Results:

  • Significant variations exist in the frequency and severity of menopausal symptoms across European countries.
  • HRT use has increased, but substantial disparities in prescription rates and types of therapy are observed between countries.
  • Factors influencing these variations likely include differing healthcare policies, cultural attitudes towards menopause, and physician prescribing habits.

Conclusions:

  • Menopausal symptom management and osteoporosis prevention remain critical public health issues in Europe.
  • Understanding the reasons behind the heterogeneous HRT use is essential for optimizing women's health outcomes.
  • Further research into country-specific factors is needed to promote equitable access to effective menopausal treatments.

Related Experiment Videos